Theolytics Limited
Clinical trials sponsored by Theolytics Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Cancer-Killing virus takes on ovarian cancer in first human trial Results expected Sep 2027 (estimated)
-
Cancer-Killing virus takes on ovarian cancer in first human trial
Disease control Recruiting nowThis early-stage trial tests a new treatment called THEO-260, a virus designed to infect and destroy cancer cells. It is given directly into the abdomen to 18 people with advanced ovarian cancer that no longer responds to platinum chemotherapy. The main goals are to find a safe d…
Phase 1 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Virus therapy takes on hard-to-treat ovarian cancer
Disease control Recruiting nowThis study tests a new treatment called THEO-260, a virus designed to attack cancer cells, in people with advanced ovarian cancer that no longer responds to platinum chemotherapy. About 44 participants will receive different doses of the virus through an IV to find a safe dose an…
Phase 1/2 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC